Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control

Kannel, 1979, Circulation, Diabetes and cardiovascular risk factors- The Framingham study, 8

Haffner, 1992, Metabolism, Lack of change of lipoprotein(a) concentration with improved glycemic control in subject with type 2 diabetes, 116

Mota,, 2008, J Bras Patol Med Lab, Lipoprotein(a) in patients with peripheral arterial obstructive disease and / or type 2 diabetes mellitus, 89

Berg, 1963, Acta Pathol Microbiol Scand, A new serum type systems in man - the Lp system, 369

Armstrong, 1986, Atherosclerosis, The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels, 249

Miles, 1990, Thromb Haemost, Lp(a): An interloper into the fibrinolytic system, 331

Arauz, 1990, Diabetes, Lipoprotein(a) levels in diabetic patients and its correlation with metabolic control, 64A

Ramirez, 1992, Ann Intern Med, Lipoprotein(a) levels in diabetes mellitus: relationship to metabolic control, 42

Chico, 1996, Diabetes Res Clin Pract, Lipoprotein(a) concentrations and noninsulin dependent mellitus: relationship to glycemic control and diabetic complications, 105

American, 1995, Diabetes Care, Standards of medical care for patients with diabetes mellitus, 8

Ahuja MMS. Epiodemiological studies on diabetes mellitus in India. In: Ahuja MMS(eds). Epidemiology of diabetes in developing countries. New Delhi: Interprint; 1979. p. 29-33.

Gambhir, 2000, Indian Heart J, Lipoprotein(a) as an independent risk factor for coronary artery disease in patients below 40 years of age, 411

Solfrizzi, 2002, Am J Cardiol, Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low density lipoprotein cholesterol in patients > or = 65 years of age, 825

Edelberg, 1990, Thromb Res, Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator, 155

Karadi, 1988, Biochem Biophys Acta, Lipoprotein(a) and plasminogen are immunochemically related, 91

Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF. A potential basis for the thrombotic risks associated with lipoprotein(a). Nature 1989;339;301-3.

Kluft, 1989, Biochem Biophys Res Commun, Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin, 427

Wollesen, 1999, Diabetes Care, Peripheral atherosclerosis and serum lipoprotein(a) in diabetes, 93

Unluhizarci, 2006, Diab Res and Clin Pract, Serum lipoprotein(a) levels in patients with diabetic foot lesions, 119

Habib, 2004, Diabetes Obes Metab, S, Aslam M.Lipids and lipoprotein (a) concentrations in Pakistani patients with type 2 diabetes mellitus, 338

Yamasaki, 2006, Diabetes Care, Uncoupling Protein 2 promoter polymorphism - 866 G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients, 888

Robert, 2009, Nature Reviews Genetics, Plasma lipoproteins: genetic influences and clinical implications, 109

Uterman, 1987, J Clin Invest, Lp(a) glycoprotein phenotypes inheritance and relation to Lp(a) lipoprotein concentrations in plasma, 458

Shi, 1998, Chin Med J, Lipoprotein(a) concentration and apolipoprotein(a) phenotype in subjects with type 2 diabetes mellitus, 1013

Hirata, 1995, Diabetologia, Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients, 1434

Heller, 1993, Diabetes Care, Serum lipoprotein(a) in patients with diabetes mellitus, 819

Wolffenbuttel, 1993, Diabet Med, Improved blood glucose control by insulin therapy in type 2 daibetic patients has no effect on lipoprotein(a) levels, 427

Alagozlu, 2000, Nutr metab Cardiovasc Dis, Lipid and lipoprotein patterns in type 2 nonobese diabetic patients.Do Lp(a) levels decrease with improved glycemic control in these patients, 204

Goolay, 1985, Diabetes, High density lipoprotein turnover in noninsulin dependent diabetes mellitus, 81A

Brown, 1994, Medical Clinics of North America, Lipoprotein disorders in diabetes mellitus, 143

Schmitt, 1982, Metabolism, Hemoglobin A1 correlates with the ratio of low to high density lipoprotein in normal weight type 2 diabetics, 1084

Guriker, 1988, Atheosclerosis, Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment, 135

Vessby, 1982, Atherosclerosis, Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a): a dose response of the eff ects of cholestyramine on hypercholesterolemia, 61